Clinical Trials Browser

Phase 3 × Gallbladder Neoplasms × Irinotecan × Clear all

NCT07265674 2026-01-23

Beacon-BTC

Phase 3 Recruiting

Gastrointestinal

Biliary Tract Neoplasms, Gallbladder Neoplasms, Cholangiocarcinoma